FBIO – fortress biotech, inc. (US:NASDAQ)
Stock Stats
News
Sentynl Therapeutics Announces U.S. FDA Acceptance and Priority Review of New Drug Application for CUTX-101 (Copper Histidinate) Product Candidate for Treatment of Menkes Disease [Yahoo! Finance]
Sentynl Therapeutics Announces U.S. FDA Acceptance and Priority Review of New Drug Application for CUTX-101 (Copper Histidinate) Product Candidate for Treatment of Menkes Disease
Fortress Biotech and Cyprium Therapeutics Announce U.S. FDA Acceptance and Priority Review of NDA for CUTX-101 for Treatment of Menkes Disease
Fortress Biotech, Inc. (NASDAQ: FBIO) had its price target raised by analysts at HC Wainwright from $24.00 to $26.00. They now have a "buy" rating on the stock.
Fortress Biotech Third Quarter 2024 Earnings: Misses Expectations [Yahoo! Finance]
Form 8-K Fortress Biotech, Inc. For: Jan 06
Form 4 Fortress Biotech, Inc. For: Jan 01 Filed by: LOBELL J JAY
Form 4 Fortress Biotech, Inc. For: Jan 01 Filed by: Lu Lucy
Form 4 Fortress Biotech, Inc. For: Jan 01 Filed by: Klein Dov
Form 4 Fortress Biotech, Inc. For: Jan 01 Filed by: Lorenz Kevin
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.